Sanichi Technology completes R&D for air ventilator
12 May 2021
Sanichi Technology Bhd has completed its research and development (R&D) phase for medical grade mechanical air ventilators, which is slated to be distributed to local and overseas healthcare markets.
The air ventilator prototype has been completed and currently commencing the application for the necessary licensing and approval by relevant authority.
The company is expected to start mass production of its air ventilator and distribution within the next six months.
Upon obtaining the necessary approval from the authority, Sanichi is scheduled to start distribution of its air ventilators to the domestic market and other countries of Asia Pacific, before expanding its distribution to Europe and the United States (US).
Managing director Datuk Seri Dr Pang Chow Huat said the progress of the company’s air ventilator production is very timely, as the number of Covid-19 cases around the world recorded are rapidly increasing, and significantly increasing the needs for air ventilators.
“Currently, we are expediting on the application for the licensing and approval by the authority. We hope to commence mass production of our air ventilator as earliest possible to meet the demand of air ventilators both for domestic and international usage,” he said in a statement today.
Pang said Malaysia has about 2.1 per cent of its population fully vaccinated, and the daily cases recorded has been increasing day to day.
“Currently we have about 500 admission to intensive unit care (ICU) recorded on May 7 2021, out of it which 216 of the patients had to be put under the assistant of an air ventilator to breathe.
“We realise that the demand for air ventilators even for our domestic market are high based on the increasing number of admission into the ICU, hence we hope that our air ventilators supply could help ease the demand within the country,” he added.
A ventilator is a machine that moves breathable air into and out of the lungs. It delivers breaths to a patient who is physically unable to breathe, or is breathing insufficiently.
The global market for ventilators is expected to increase from US$1.05 billion in 2019 to US$3.02 billion by 2027 with a compound annual growth rate (CAGR) of 13.96 per cent.
With the rapidly increasing number of Covid-19 infection reaching 158 million globally, thus significantly increase the demand for air ventilators.
The largest installed base of the ventilators is in the US, and the region itself still has a requirement of 85,000 ventilators to cope with Covid-19 pandemic.
Various regulatory agencies across North America, Europe, Asia Pacific and Latin America have modified their regulations and approval process for air ventilators.